NL7508437A - Vitaminepreparaten. - Google Patents

Vitaminepreparaten.

Info

Publication number
NL7508437A
NL7508437A NL7508437A NL7508437A NL7508437A NL 7508437 A NL7508437 A NL 7508437A NL 7508437 A NL7508437 A NL 7508437A NL 7508437 A NL7508437 A NL 7508437A NL 7508437 A NL7508437 A NL 7508437A
Authority
NL
Netherlands
Prior art keywords
vitamin preparations
vitamin
preparations
Prior art date
Application number
NL7508437A
Other languages
English (en)
Other versions
NL167092B (nl
NL167092C (nl
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NL7508437A publication Critical patent/NL7508437A/nl
Publication of NL167092B publication Critical patent/NL167092B/nl
Application granted granted Critical
Publication of NL167092C publication Critical patent/NL167092C/nl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL7508437.A 1975-02-14 1975-07-15 Werkwijze voor de bereiding van vitamine a-propionaat preparaten, die een niet-ionogene emulgator bavatten. NL167092C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH189775 1975-02-14

Publications (3)

Publication Number Publication Date
NL7508437A true NL7508437A (nl) 1976-08-17
NL167092B NL167092B (nl) 1981-06-16
NL167092C NL167092C (nl) 1981-11-16

Family

ID=4221142

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7508437.A NL167092C (nl) 1975-02-14 1975-07-15 Werkwijze voor de bereiding van vitamine a-propionaat preparaten, die een niet-ionogene emulgator bavatten.

Country Status (11)

Country Link
US (1) US4075333A (nl)
JP (1) JPS603044B2 (nl)
BE (1) BE831363A (nl)
CA (1) CA1043258A (nl)
DE (1) DE2526938C2 (nl)
ES (1) ES439106A1 (nl)
FR (1) FR2300554A1 (nl)
GB (1) GB1471797A (nl)
MX (1) MX172916B (nl)
NL (1) NL167092C (nl)
ZA (1) ZA754011B (nl)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3048000A1 (de) * 1980-12-19 1982-07-15 Basf Ag Stabile injizierbare (beta)-carotin-solubilisate und verfahren zu ihrer herstellung
US4308264A (en) * 1981-01-28 1981-12-29 Abbott Laboratories Stabilized, dilute aqueous preparation of 1α,25-dihydroxycholecalciferol for neonatal administration
HU185533B (en) * 1982-05-21 1985-02-28 Richter Gedeon Vegyeszet Process for producing concentrated hydrosoles containing h lipophilic and hydrophilic vitamines
DE3241113A1 (de) * 1982-11-06 1984-05-10 Bayer Ag, 5090 Leverkusen Vakzinen mit zuschlagstoffen
DE3381777D1 (de) * 1982-12-09 1990-09-06 Advanced Drug Tech Einfach absorbierbare fettsaeureemulsionen.
US4612194A (en) * 1984-02-15 1986-09-16 Roshdy Ismail Anti-rheumatic agents and their use
US4572915A (en) * 1984-05-01 1986-02-25 Bioglan Laboratories Clear micellized solutions of fat soluble essential nutrients
US4784845A (en) * 1985-09-16 1988-11-15 American Cyanamid Company Emulsion compostions for the parenteral administration of sparingly water soluble ionizable hydrophobic drugs
JPS62106018A (ja) * 1985-11-01 1987-05-16 Santen Pharmaceut Co Ltd 高濃度ビタミンe水性製剤
DE4031094A1 (de) * 1990-10-02 1992-04-09 Basf Ag Verfahren zur herstellung von stabilen injizierbaren (beta)-carotin-solubilisaten
US5631287A (en) * 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
US6011062A (en) * 1994-12-22 2000-01-04 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
KR19990071255A (ko) * 1998-02-28 1999-09-15 성재갑 소마토트로핀과 비타민의 합제 조성물
DE60140141D1 (de) * 2000-11-14 2009-11-19 Vital Health Sciences Pty Ltd Zusammensetzungen umfassend Komplexe von Tocopherolphosphatderivaten
AUPR549901A0 (en) * 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
US6774100B2 (en) 2000-12-06 2004-08-10 Imaginative Research Associates, Inc. Anhydrous creams, lotions and gels
US7060732B2 (en) * 2000-12-12 2006-06-13 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
US6462025B2 (en) 2000-12-12 2002-10-08 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
US20060189552A1 (en) * 2000-12-12 2006-08-24 Mohan Vishnupad Dispenser for dispensing three or more actives
WO2002076442A1 (fr) * 2001-03-27 2002-10-03 Santen Pharmaceutical Co., Ltd. Preparation liquide aqueuse stable
CN1547475B (zh) * 2001-07-27 2010-12-15 生命健康科学有限公司 含电子转移试剂的磷酸酯衍生物的皮肤制剂
US7081248B2 (en) * 2001-08-03 2006-07-25 Adisseo France S.A.S. Concentrated water-dispersible vitamin compositions
BR0214679A (pt) * 2001-12-03 2004-12-14 Novacea Inc Composições farmacêuticas compreendendo compostos a base de vitamina d ativa
BR0215102A (pt) * 2001-12-13 2004-11-03 Vital Health Sciences Pty Ltd Transporte transdermal de compostos, formulação tópica, método para melhorar a absorção da pele, método para a terapia de reposição hormonal, uso de um ou mais derivados de fosfato de um composto hidróxi farmacêutico em um sistema de aplicação transdermal, sistema de aplicação transdermal, método para aplicação de um composto hidróxi farmacêutico a um indivìduo e para melhorar a eficácia de uma formulação
AU2002950713A0 (en) * 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
US20040058895A1 (en) * 2002-09-18 2004-03-25 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US20040053895A1 (en) * 2002-09-18 2004-03-18 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US20050026877A1 (en) * 2002-12-03 2005-02-03 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
ATE534384T1 (de) * 2003-01-17 2011-12-15 Vital Health Sciences Pty Ltd Verbindungen mit proliferationshemmenden eigenschaften
AU2003901815A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
US20060189586A1 (en) * 2003-06-11 2006-08-24 Cleland Jeffrey L Pharmaceutical compositions comprising active vitamin D compounds
US20050020546A1 (en) * 2003-06-11 2005-01-27 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
ATE495730T1 (de) * 2004-03-03 2011-02-15 Vital Health Sciences Pty Ltd Alkaloid-formulierungen
JP2008531602A (ja) * 2005-03-03 2008-08-14 バイタル ヘルス サイエンシズ プロプライアタリー リミティド 抗癌特性を有する化合物
MX2007015949A (es) * 2005-06-17 2008-03-07 Vital Health Sciences Pty Ltd Un vehiculo que comprende uno o mas derivados de fosfato de di- y/o mono-(agentes de transferencia de electrones) o complejos de los mismos.
KR20080085839A (ko) * 2005-12-23 2008-09-24 바이탈 헬스 사이언시즈 피티와이 리미티드 사이토킨 조절 특성을 가진 화합물
JP5275229B2 (ja) 2006-06-27 2013-08-28 アクゾ ノーベル ナムローゼ フェンノートシャップ ビタミンを含む組成物及び強化飼料及びパーソナルケア組成物を作る為にそれらを使用する方法
EP2531047A4 (en) 2010-02-05 2014-03-19 Phosphagenics Ltd CARRIER WITH AN UNINUTRALIZED TOCOPHERYL PHOSPHATE
CA2794734C (en) 2010-03-30 2017-12-12 Phosphagenics Limited Transdermal delivery patch
US9561243B2 (en) 2011-03-15 2017-02-07 Phosphagenics Limited Composition comprising non-neutralised tocol phosphate and a vitamin A compound
CN107750155A (zh) * 2015-05-22 2018-03-02 费森尤斯卡比德国有限公司 用于肠胃外给药的维生素a
WO2016188876A1 (en) * 2015-05-22 2016-12-01 Fresenius Kabi Deutschland Gmbh Vitamin a for parenteral administration
CN108601732A (zh) 2015-12-09 2018-09-28 磷肌酸有限公司 药物制剂
WO2018112512A1 (en) 2016-12-21 2018-06-28 Phosphagenics Limited Process

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3070499A (en) * 1960-09-19 1962-12-25 Merck & Co Inc Parenteral aqueous solutions of fat soluble vitamins
US3149037A (en) * 1962-09-07 1964-09-15 Hoffmann La Roche Vitamin compositions
FR1370929A (fr) * 1963-09-06 1964-08-28 Hoffmann La Roche Procédé pour la préparation de compositions vitaminées
US3244595A (en) * 1965-05-07 1966-04-05 Mattox And Moore Inc Composition for administering vitamins a, d, and e
DE2019839A1 (de) * 1969-04-28 1970-11-05 Ferrosan As Stabile,klare,wasserdispergierbare bzw.-verduennbare,Vitamin-A enthaltende Loesung und Verfahren zu ihrer Herstellung
US3639587A (en) * 1969-11-07 1972-02-01 Eastman Kodak Co Medicinal compositions for administration to animals and process for administering same
US3708583A (en) * 1970-04-03 1973-01-02 Vitamin Premixers Of Omaha Inc Stabilized vitamin a additive
NL7012460A (nl) * 1970-08-22 1972-02-24
US3932634A (en) * 1973-06-28 1976-01-13 Pfizer Inc. High potency vitamin water dispersible formulations

Also Published As

Publication number Publication date
ES439106A1 (es) 1977-07-01
DE2526938C2 (de) 1982-04-22
JPS5195123A (en) 1976-08-20
FR2300554B1 (nl) 1979-10-12
AU8249875A (en) 1977-01-06
GB1471797A (en) 1977-04-27
CA1043258A (en) 1978-11-28
NL167092B (nl) 1981-06-16
DE2526938A1 (de) 1976-08-26
ZA754011B (en) 1976-09-29
BE831363A (fr) 1976-01-15
US4075333A (en) 1978-02-21
NL167092C (nl) 1981-11-16
FR2300554A1 (fr) 1976-09-10
MX172916B (es) 1994-01-20
JPS603044B2 (ja) 1985-01-25

Similar Documents

Publication Publication Date Title
NL7508437A (nl) Vitaminepreparaten.
NL7610279A (nl) Bindmiddelpreparaten.
ATA971076A (de) Erbizide zubereitungen
NL7613107A (nl) Fungicide preparaten.
NL7603600A (nl) Darmpreparaat.
NL7607993A (nl) Ortho-aminobutyrofenonderivaten.
DK280077A (da) Vitaminpreparat
NO141839C (no) Enkeltpunkts-fortoeyningsboeye.
NL7608376A (nl) Thermoplastische vormpreparaten.
NL7606712A (nl) Oestrogeen-prostaglandine-combinatiepreparaat.
BE849303A (fr) Tranducteur.
NL7607939A (nl) Anthelmintische preparaten.
NL7611172A (nl) Thiazolinylaminopiperidinederivaten.
NL7704084A (nl) Medicinale preparaten.
NL7613452A (nl) Farmaceutische anti-fertiliteitspreparaten.
NL7606262A (nl) Polyketonderivaten.
NL7611175A (nl) Piperidinylguanidinederivaten.
NL7712100A (nl) Farmaceutische preparaten.
NL7600044A (nl) Farmaceutische combinatiepreparaten.
NL7601605A (nl) 3-fenyl-sec.butylaminederivaten.
DK151559C (da) Kartonaeske.
ES209316Y (es) Muneco mecanico.
ES212889Y (es) Cohete-senal.
NL7610799A (nl) Triazolylbenzofenonderivaten.
ES217760Y (es) Plantigrafo.

Legal Events

Date Code Title Description
SNR Assignments of patents or rights arising from examined patent applications

Owner name: F. HOFFMANN-LA ROCHE AG

V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 950715